RU2006118786A - Твердый препарат - Google Patents
Твердый препарат Download PDFInfo
- Publication number
- RU2006118786A RU2006118786A RU2006118786/15A RU2006118786A RU2006118786A RU 2006118786 A RU2006118786 A RU 2006118786A RU 2006118786/15 A RU2006118786/15 A RU 2006118786/15A RU 2006118786 A RU2006118786 A RU 2006118786A RU 2006118786 A RU2006118786 A RU 2006118786A
- Authority
- RU
- Russia
- Prior art keywords
- solid preparation
- agent
- preparation according
- insulin
- solid drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Claims (6)
1. Твердый препарат, содержащий сенсибилизатор инсулина, средство, стимулирующее секрецию инсулина, и сложный эфир полиоксиэтиленсорбитана и жирной кислоты.
2. Твердый препарат по п.1, где указанный сенсибилизатор инсулина представляет собой гидрохлорид пиоглитазона.
3. Твердый препарат по п.1, где указанное средство, стимулирующее секрецию инсулина, представляет собой агент на основе сульфонилмочевины.
4. Твердый препарат по п.3, где указанный агент на основе сульфонилмочевины представляет собой глимепирид.
5. Твердый препарат по п.1, где указанный сложный эфир полиоксиэтиленсорбитана и жирной кислоты представляет собой полисорбат 80.
6. Твердый препарат, содержащий гидрохлорид пиоглитазона, глимепирид и полисорбат 80.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003-371679 | 2003-10-31 | ||
JP2003371679 | 2003-10-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2006118786A true RU2006118786A (ru) | 2007-12-10 |
RU2359661C2 RU2359661C2 (ru) | 2009-06-27 |
Family
ID=34543966
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2006118786/15A RU2359661C2 (ru) | 2003-10-31 | 2004-10-21 | Твердый препарат |
Country Status (28)
Country | Link |
---|---|
US (1) | US7700128B2 (ru) |
EP (1) | EP1677792B1 (ru) |
KR (2) | KR20100012105A (ru) |
CN (1) | CN1874774B (ru) |
AR (1) | AR046210A1 (ru) |
AU (1) | AU2004285354B2 (ru) |
BR (1) | BRPI0414979A (ru) |
CA (1) | CA2540225C (ru) |
CY (1) | CY1117176T1 (ru) |
DK (1) | DK1677792T3 (ru) |
ES (1) | ES2556244T3 (ru) |
GE (1) | GEP20084570B (ru) |
HR (1) | HRP20151447T1 (ru) |
HU (1) | HUE028576T2 (ru) |
IL (1) | IL174201A (ru) |
JO (1) | JO3106B1 (ru) |
MA (1) | MA28116A1 (ru) |
MX (1) | MXPA06004639A (ru) |
NO (1) | NO340294B1 (ru) |
NZ (1) | NZ546337A (ru) |
PE (1) | PE20050923A1 (ru) |
PL (1) | PL1677792T3 (ru) |
PT (1) | PT1677792E (ru) |
RU (1) | RU2359661C2 (ru) |
SI (1) | SI1677792T1 (ru) |
TW (1) | TWI339586B (ru) |
WO (1) | WO2005041962A1 (ru) |
ZA (1) | ZA200602056B (ru) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050220881A1 (en) * | 2003-10-10 | 2005-10-06 | Bvm Holding Co. | Pharmaceutical composition |
MXPA05013220A (es) * | 2005-12-06 | 2007-06-05 | Leopoldo De Jesus Espinosa Abdala | Composiciones farmaceuticas que comprenden sustancias antidiabeticas combinadas para su uso en diabetes mellitus tipo 2. |
TWI384985B (zh) * | 2005-12-22 | 2013-02-11 | Takeda Pharmaceutical | 固體製劑 |
CN101478966B (zh) | 2006-06-27 | 2013-08-21 | 第一三共株式会社 | 压缩制剂 |
BRPI0807453B8 (pt) * | 2007-02-01 | 2021-05-25 | Takeda Pharmaceuticals Co | preparação sólida |
IS8660A (is) * | 2007-07-02 | 2009-01-03 | Actavis Group Ptc Ehf. | Gliklasíð lyfjasamsetning |
WO2009120844A2 (en) * | 2008-03-26 | 2009-10-01 | Teva Pharmaceutical Industries Ltd. | Pharmaceutical compositions comprising insulin sensitizer and insulin secretagogue |
CA2782776A1 (en) | 2008-12-04 | 2010-06-10 | Ikfe Gmbh | Biomarkers for atherosclerosis |
US20110118134A1 (en) | 2008-12-11 | 2011-05-19 | Ikfe Gmbh | Biomarkers for insulin sensitizer drug response |
WO2010076655A1 (en) | 2008-12-30 | 2010-07-08 | Ikfe Gmbh | Biomarkers for adipose tissue activity |
EP2382475A2 (en) | 2009-01-07 | 2011-11-02 | IKFE GmbH | Biomarkers for appetite regulation |
US8623345B2 (en) * | 2009-03-20 | 2014-01-07 | Smartcells | Terminally-functionalized conjugates and uses thereof |
EP2618827B1 (en) * | 2010-09-21 | 2021-06-02 | Intekrin Therapeutics, Inc. | Antidiabetic solid pharmaceutical compositions |
EP2438911A1 (en) * | 2010-10-08 | 2012-04-11 | LEK Pharmaceuticals d.d. | Pharmaceuticals compositions comprising sulphonylurea-class insulin secretagogue and polyethylene glycol castor oil |
WO2013034174A1 (en) * | 2011-09-06 | 2013-03-14 | ZENTIVA Saglik Ürünleri Sanayi ve Ticaret A.S. | Solid preparations of pioglitazone and glimepiride |
CN104288161A (zh) * | 2014-09-19 | 2015-01-21 | 四川海思科制药有限公司 | 一种含吡格列酮格列美脲的药物组合物 |
CA2979033A1 (en) | 2015-03-09 | 2016-09-15 | Intekrin Therapeutics, Inc. | Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy |
US11253508B2 (en) | 2017-04-03 | 2022-02-22 | Coherus Biosciences, Inc. | PPARy agonist for treatment of progressive supranuclear palsy |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5865213A (ja) * | 1981-10-13 | 1983-04-18 | Tokai Kapuseru Kk | dl−2−(4,8,12−トリメチルトリデシル)−2,5,7,8−テトラメチル−6−クロマニルニコチネ−ト軟カプセル剤 |
US4620974A (en) * | 1983-07-07 | 1986-11-04 | American Home Products Corporation | Pharmaceutical composition containing a liquid lubricant |
JP2764274B2 (ja) * | 1988-03-28 | 1998-06-11 | 株式会社ミドリ十字 | 医薬組成物 |
PT726761E (pt) | 1993-11-03 | 2001-07-31 | Isomed Inc | Composicoes farmaceuticas que microparticulas na forma de micelios |
HU212428B (en) * | 1994-05-13 | 1996-06-28 | Egyt Gyogyszervegyeszeti Gyar | Process to prepare pharmaceutical compositions containing gemfibrozyl |
TWI238064B (en) * | 1995-06-20 | 2005-08-21 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
AU6944296A (en) | 1995-09-13 | 1997-04-01 | Takeda Chemical Industries Ltd. | Benzoxazepine compounds, their production and use as lipid lowering agents |
GB9619757D0 (en) * | 1996-09-21 | 1996-11-06 | Knoll Ag | Chemical process |
FR2758461A1 (fr) * | 1997-01-17 | 1998-07-24 | Pharma Pass | Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation |
US5859037A (en) | 1997-02-19 | 1999-01-12 | Warner-Lambert Company | Sulfonylurea-glitazone combinations for diabetes |
US6011049A (en) | 1997-02-19 | 2000-01-04 | Warner-Lambert Company | Combinations for diabetes |
US6291495B1 (en) | 1997-02-24 | 2001-09-18 | Robert B. Rieveley | Method and composition for the treatment of diabetes |
US6025372A (en) | 1997-04-04 | 2000-02-15 | Merck & Co., Inc. | Somatostatin agonists |
US6057338A (en) | 1997-04-04 | 2000-05-02 | Merck & Co., Inc. | Somatostatin agonists |
AP1600A (en) * | 1997-06-18 | 2006-04-28 | Smithkline Beecham Plc | Combination of a thiazolidinedione and a sulphonylurea for treating diabetes |
GB9715298D0 (en) | 1997-07-18 | 1997-09-24 | Smithkline Beecham Plc | Novel method of treatment |
GB9715306D0 (en) | 1997-07-18 | 1997-09-24 | Smithkline Beecham Plc | Novel method of treatment |
GB9715295D0 (en) | 1997-07-18 | 1997-09-24 | Smithkline Beecham Plc | Novel method of treatment |
EA002806B1 (ru) * | 1997-09-11 | 2002-10-31 | Нюкомед Данмарк А/С | Многоединичные композиции с модифицированным высвобождением нестероидных противовоспалительных лекарственных веществ (nsaid) |
AU1285499A (en) | 1997-10-30 | 1999-05-24 | Merck & Co., Inc. | Somatostatin agonists |
BR9915285A (pt) | 1998-11-12 | 2001-08-07 | Smithkline Beecham Plc | Composição farmacêutica para liberação modificada de um sensitivador de insulina e um outro agente antidiabético |
AR035016A1 (es) | 1999-08-25 | 2004-04-14 | Takeda Chemical Industries Ltd | Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima. |
CA2386517A1 (en) | 1999-10-07 | 2001-04-12 | Takeda Chemical Industries, Ltd. | Amine derivatives |
US20030180352A1 (en) | 1999-11-23 | 2003-09-25 | Patel Mahesh V. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US6793934B1 (en) | 1999-12-08 | 2004-09-21 | Shire Laboratories, Inc. | Solid oral dosage form |
US20010036479A1 (en) | 2000-01-14 | 2001-11-01 | Gillian Cave | Glyburide composition |
ATE479429T1 (de) | 2000-04-28 | 2010-09-15 | Takeda Pharmaceutical | Antagonisten des melanin-konzentrierenden hormons |
US6524621B2 (en) | 2000-05-01 | 2003-02-25 | Aeropharm Technology Inc. | Core formulation |
AU2001256733A1 (en) | 2000-05-16 | 2001-11-26 | Takeda Chemical Industries Ltd. | Melanin-concentrating hormone antagonist |
EP1349531A1 (en) | 2001-01-12 | 2003-10-08 | Sun Pharmaceuticals Industries Ltd. | Spaced drug delivery system |
US20050245571A1 (en) | 2001-10-19 | 2005-11-03 | Hidenori Abe | Amine derivative |
US6682759B2 (en) * | 2002-02-01 | 2004-01-27 | Depomed, Inc. | Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs |
EP1552832A1 (en) | 2002-07-11 | 2005-07-13 | Takeda Pharmaceutical Company Limited | Process for producing coated preparation |
UA80991C2 (en) | 2002-10-07 | 2007-11-26 | Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes | |
US20040147564A1 (en) | 2003-01-29 | 2004-07-29 | Rao Vinay U. | Combinations of glimepiride and the thiazolidinedione for treatment of diabetes |
NZ541749A (en) | 2003-01-29 | 2009-06-26 | Takeda Pharmaceutical | Process for producing coated preparation comprising pioglitazone hydrochloride and a coating material |
FR2853831A1 (fr) * | 2003-03-05 | 2004-10-22 | Usv Ltd | Forme posologique solide a usage oral de metformine et de glyburide et son procede de preparation |
-
2004
- 2004-10-21 HU HUE04793070A patent/HUE028576T2/en unknown
- 2004-10-21 CA CA2540225A patent/CA2540225C/en active Active
- 2004-10-21 RU RU2006118786/15A patent/RU2359661C2/ru not_active IP Right Cessation
- 2004-10-21 PT PT47930706T patent/PT1677792E/pt unknown
- 2004-10-21 US US10/544,581 patent/US7700128B2/en active Active
- 2004-10-21 SI SI200432292T patent/SI1677792T1/sl unknown
- 2004-10-21 PL PL04793070T patent/PL1677792T3/pl unknown
- 2004-10-21 BR BRPI0414979-3A patent/BRPI0414979A/pt not_active IP Right Cessation
- 2004-10-21 TW TW093131948A patent/TWI339586B/zh not_active IP Right Cessation
- 2004-10-21 GE GEAP20049366A patent/GEP20084570B/en unknown
- 2004-10-21 CN CN2004800325205A patent/CN1874774B/zh active Active
- 2004-10-21 NZ NZ546337A patent/NZ546337A/en not_active IP Right Cessation
- 2004-10-21 WO PCT/JP2004/015958 patent/WO2005041962A1/en active Application Filing
- 2004-10-21 EP EP04793070.6A patent/EP1677792B1/en active Active
- 2004-10-21 ES ES04793070.6T patent/ES2556244T3/es active Active
- 2004-10-21 ZA ZA200602056A patent/ZA200602056B/en unknown
- 2004-10-21 KR KR1020107001527A patent/KR20100012105A/ko not_active Application Discontinuation
- 2004-10-21 AU AU2004285354A patent/AU2004285354B2/en not_active Ceased
- 2004-10-21 DK DK04793070.6T patent/DK1677792T3/en active
- 2004-10-21 MX MXPA06004639A patent/MXPA06004639A/es active IP Right Grant
- 2004-10-21 KR KR1020067007458A patent/KR100952090B1/ko active IP Right Grant
- 2004-10-27 PE PE2004001032A patent/PE20050923A1/es not_active Application Discontinuation
- 2004-10-28 JO JOP/2004/0148A patent/JO3106B1/ar active
- 2004-10-28 AR ARP040103930A patent/AR046210A1/es not_active Application Discontinuation
-
2006
- 2006-03-09 IL IL174201A patent/IL174201A/en not_active IP Right Cessation
- 2006-04-28 MA MA28976A patent/MA28116A1/fr unknown
- 2006-05-31 NO NO20062515A patent/NO340294B1/no unknown
-
2015
- 2015-12-31 HR HRP20151447TT patent/HRP20151447T1/hr unknown
-
2016
- 2016-01-28 CY CY20161100077T patent/CY1117176T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2006118786A (ru) | Твердый препарат | |
NO20043702L (no) | 8-azaprostaglandinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel | |
DE60333294D1 (de) | Kontrollierte verabreichung von arzneien | |
DK1498411T3 (da) | Diketohydrazinderivatforbindelser og medikamenter indeholdende forbindelserne som den aktive bestanddel | |
EA200600598A1 (ru) | Лекарственные формы замедленного высвобождения | |
ATE374016T1 (de) | Tablette mit hohem wirkstoffgehalt | |
ATE454138T1 (de) | Tablette mit modifizierter freisetzung von bupropion hydrochlorid | |
NO20040564L (no) | Karboksylsyrederivatforbindelser og legemidler omfattende disse forbindelser som den aktive bestanddel | |
RU2004110055A (ru) | Новые ингибиторы дипептидил пептидазы iv в качестве антидиабетических агентов | |
DE60331153D1 (de) | Reboxetin enthaltende tablette mit verzögerter wirkstoffabgabe | |
DK1557415T3 (da) | Heterocykliske forbindelser og antitumorlægemidler indeholdende samme som den aktive ingrediens | |
ATE273304T1 (de) | (s)-4-amino-5-chloro-2-methoxy-n-(1-(1-(2- tetrahydrofuryl-carbonyl)-4-piperidinylmethyl)- - piperidinyl)benzamid zur behandlung von magen- darmbewegungskrankheiten | |
RU2008116176A (ru) | Стимулятор секреции глюкагон-подобного пептида 1, продукты питания или напитки, стимулирующие секрецию глюкагон-подобного пептида 1, ингибитор постпрандиальной гипергликемии и продукта питания или напитки, ингибирующие постпрандиальную гипергликемию | |
DE502004005560D1 (de) | Pharmazeutische formulierungen enthaltend hochreine basen von 3,3-diphenylpropylaminmonoestern | |
CA2489140A1 (en) | Dosage form containing pantoprazole as active ingredient | |
EP1669065A4 (en) | DRUGS WITH (2R) -2-PROPYLOCTANIC ACID AS ACTIVE SUBSTANCE | |
NO20043483L (no) | Anvendelse av melagatran for fremstilling av et medikament for behandling av type 1 Diabetes mellitus | |
ATE404192T1 (de) | Verwendung von nefiracetam zur behandlung von postischemischer neurodegeneration | |
RU2003104017A (ru) | Ингибиторы тромбина, содержащие аминоизохинолиновую группу | |
DE60302951D1 (de) | Pyroglutaminsäure-salz von Amlodipin | |
JP2004525111A5 (ru) | ||
NO20043397L (no) | Prucaloprid-N-oksid | |
ATE439354T1 (de) | Pharmazeutische salze von reboxetin | |
NO20031030L (no) | Nye krystaller av N-hydroksy-2(S)-metyl-5-etoksymetoksy-4(S)- [N-(4-fenoksyfenylkarbonyl)amino]pentanamid, fremgangsmåte for deresfremstilling og medisinerinneholdende krystallene som den aktive bestanddel | |
DE60327249D1 (de) | Anthranilsäureamide und ihre pharmazeutische verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20151022 |